Allelic imbalance mapping of chromosome 16 shows two regions of common deletion in prostate adenocarcinoma

Cancer Genetics and Cytogenetics

Volumn 98, Issue 1, 1997, Pages 36-42

  Godfrey, Tony E ^a   Cher, Michael L ^a   Chhabra, Vikas ^a   Jensen, Ronald H ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UVOMORULIN;

ALLELISM; ARTICLE; CHROMOSOME 16Q; GENE DELETION; GENE LOCUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; LIVER CELL CARCINOMA; NEPHROBLASTOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ALLELES; CADHERINS; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 16; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS;

EID: 0030801319     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00392-5     Document Type: Article

References (36)

1. Sato T, Tanigami A, Yamakawa K, Akiyama F, Kasumi F, Sakamoto G, Nakamura Y (1990): Allelotype of breast cancer: Cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res 50:7184-7189.
2. Kunimi K, Bergerheim USR, Larsson I-L, Ekman P, Collins VP (1991): Allelotyping of human prostatic adenocarcinoma. Genomics 11:530-536.
3. Bonsing BA, Devilee P, Cleton-Jansen A-M, Kuipers-Dijkshoorn N, Fleuren GJ, Cornelisse CJ (1993): Evidence for limited molecular heterogeneity as defined by allelotyping and clonal analysis in nine metastatic breast carcinomas. Cancer Res 53:3804-3811.
4. MacGrogan D, Levy A, Bostwick D, Wagner M, Wells D, Bookstein R (1994): Loss of chromosome 8p loci in prostate cancer: Mapping by quantitative allelic imbalance. Genes Chromosom Cancer 10:151-159.
5. Sakr WA, Macoska JA, Benson P, Grignon DJ, Wolman SR, Pontes JE, Chrissman JD (1994): Allelic loss in locally metastatic, multisampled prostate cancer. Cancer Res 54:3273-3277.
6. Bergerheim USR, Kunimi K, Collins VP, Ekman P (1991): Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma. Genes Chromosom Cancer 3:215-220.
7. Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI, Isaacs WB (1990): Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 87:8751-8755.
8. Tsuda H, Callen DF, Fukutomi T, Nakamura Y, Hirohashi S (1994): Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespective of differences in phenotype and extent of spread. Cancer Res 54:513-517.
9. Cleton-Jansen A-M, Moerland EW, Kuipers-Dijkshoorn NJ, Callen DF, Sutherland GR, Hansen B, Devilee P, Cornelisse CJ (1994): At least two different regions are involved in allelic imbalance on chromosome 16q in breast cancer. Genes Chromosom Cancer 9:101-107.
10. Lindblom A, Rotstein S, Skoog L, Nordenskjold M, Larsson C (1993): Deletions on chromosome 16 in familial breast carcinomas are associated with development of distant metastases. Cancer Res 53:3707-3711.
11. Sato T, Akiyama F, Sakamoto G, Kasumi F, Nakamura Y (1991): Accumulation of genetic alterations and progression of primary breast cancer. Cancer Res 51:5794-5799.
12. Cher ML, MacGrogan D, Bookstein R, Brown JA, Jenkins RB, Jensen RH (1994): Comparative genome hybridization, allelic imbalance and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chromosom Cancer 11:153-162.
13. Phillips SMA, Morton DG, Lee SJ, Wallace DMA, Neoptolemos JP (1994): Loss of heterozygosity of the retinoblastoma and adenomatous polyposis susceptibility gene loci and in chromosomes 10p, 10q, and 16q in human prostate cancer. Br J Urol 73:390-395.
14. Tsuda H, Zhang W, Shimosato Y, Yokota J, Terada M, Sugimura T, Miyamura T, Hirohashi S (1990): Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA 87:6791-6794.
15. Maw M, Grundy PE, Millow LJ, Eccles MR, Dunn RS, Smith PJ, Feinberg AP, Law DJ, Paterson MC, Tezerow PE, Callen DF, Thompson AD, Richards RI, Reeve AE (1992): A third Wilms' tumor locus on chromosome 16q. Cancer Res 52: 3094-3098.
16. Cher ML, Ito T, Weidner N, Carroll PR, Jensen RH (1995): Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization. J Urol 153:249-254.
17. Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Sokhom SP, Epstein JI, Isaacs WB, Jensen RH (1996): Genetic alterations in untreated prostate cancer metastases and androgen independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res 56:3091-3102.
18. Isola J, DeVries S, Chu L, Ghazvini S, Waldman F (1994): Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am J Pathol 145:1301-1308.
19. Austruy E, Jeanpierre C, Antignac C, Whitmore SA, Van Cong N, Bernheim A, Callen DF, Junien C (1993): Physical and genetic mapping of the dipeptidase gene DPEP1 to 16q24.3. Genomics 15:684-687.
20. Pullman WE, Bodmer WF (1992): Cloning and characterization of a gene that regulates cell adhesion. Nature 356:529-532.
21. Chhajlani V, Wikberg JES (1992): Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett. 309:417-420.
22. Adams MS, Helps NR, Sharp MG, Brammar WJ, Walker RA, Varley JM (1992): Isolation and characterization of a novel gene with differential expression in benign and malignant human breast tumors. Human Mol Genet 1:91-96.
23. Ray R, Miller DM (1991): Cloning and characterization of a human c-myc promoter-binding protein. Mol Cell Biol 11: 2154-2161.
24. Scheuman GF, Hoang-Vu C, Cetin Y, Gimm O, Behrends J, von Wasielewski R, Georgii A, Birchmeier W, von Zur Muhlen A, Dralle H (1995): Clinical significance of E-cadherin as a prognostic marker in thyroid carcinomas. J Clin Endocrinol Metabol 80:2168-2172.
25. Lipponen PK, Eskelinen MJ (1995): Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancer. J Cancer Res Clin Oncol 121:303-308.
26. Dorudi S, Hanby AM, Poulsom R, Northover J, R HI (1995): Level of expression of E-cadherin mRNA in colorectal cancer correlates with clinical outcome. Br J Cancer 71:614-616.
27. Katagiri A, Watanabe R, Tomita Y (1995): E-cadherin expression in renal cell cancer and its significance in metastasis and survival. Br J Cancer 71:376-379.
28. Umbas R, Isaacs WB, Bringuier PP, Schaafsma HE, Karthaus HF, Oosterhof GO, Debruyne FM, Schalken JA (1994): Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 54: 3929-3933.
29. Mattijssen V, Peters HM, Schalkwijk L, Manni JJ, van t'Hof Grootenboer B, de Mulder PH, Ruiter DJ (1993): E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome. Int J Cancer 55:580-585.
30. Risinger JI, Berchuck A, Kohler MF, Boyd J (1994): Mutations of the E-cadherin gene in human gynecologic cancers. Nature Genet 7:98-102.
31. Oda T, Kanai Y, Oyama T, Yoshiura K, Shimoyama Y, Birchmeier W, Sugimura T, Hirohashi S (1994): E-cadherin gene mutations in human gastric carcinoma cell lines. Proc Natl Acad Sci USA 91:1858-1862.
32. Becker KF, Atkinson MJ, Reich U, Huang HH, Nekarda H, Siewert JR, Hofler H (1993): Exon skipping in the E-cadherin gene transcript in metastatic human gastric carcinomas. Human Mol Genet 2:803-804.
33. Kanai Y, Oda T, Tsuda H, Ochiai A, Hirohashi S (1994): Point mutation of the E-cadherin gene in invasive lobular carcinoma of the breast. Jap J Cancer Res 85:1035-1039.
34. Berx G, Cleton-Jansen A-M, Nollet F, de Leeuw WJ, van de Vijver M, Cornelisse C, van Roy F (1995): E-cadherin is a tumor/invasion suppressor gene mutated in human lobular breast cancers. EMBO 14:6107-6115.
35. Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, Isaacs WB, Pitha PM, Davidson NE, Baylin SB (1995): E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 55:5195-5199.
36. Gleason DF (1966): Classification of prostatic carcinomas. Cancer Chemother Rep 50:125-128.